SEC Form 4 · accession 0001209191-15-054319
Tvardi Therapeutics, Inc. · TVRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederique Menzaghi Ph.D.
Officer — VP-Research & Development
Period of report
Jun 15, 2015
Accepted (ET)
Jun 17, 2015 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001346830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $10.82 | Jun 15, 2015 | A | 60,000 | A | — | Jun 15, 2025 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The shares shall vest and become exercisable in a series of 48 successive equal monthly installments measured from February 1, 2015, subject to the reporting person's continuous service with the issuer as of each such date.